Antidepressant efficacy and side effect burden: an updated guide for clinicians

Tatum Kutzer DO, Michelle Dick MD, Trevor Scudamore MD, Mark Wiener MD, Thomas Schwartz MD

Article Type

Review

Published

This article serves to provide clinicians with updated information about novel antidepressant medications, augmentation strategies with atypical antipsychotics, over-the-counter medications, as well as nonpharmaceutical treatments that should be considered when treating each individual patient who remains symptomatic despite treatment efforts.

Read more

Anti-NMDA receptor encephalitis: a case study and illness overview

Brian Ford MD, Alex McDonald MD, Shilpa Srinivasan MD, DFAPA

Article Type

Review

Published

This review on anti-N-methyl D-aspartate (NMDA) receptor (anti-NMDAR) encephalitis provides a case presentation and the timeline of symptoms seen over the course of the illness. Key findings in the literature about anti-NMDAR encephalitis are highlighted to facilitate diagnostic consideration and treatment.

Read more

Exploring the association of legalisation status of cannabis with problematic cannabis use and impulsivity in the USA

Louise Destrée BPsych (Hons), Danielle Amiet BPsych (Hons), Adrian Carter PhD, Rico Lee PhD, Valentina Lorenzetti PhD, Rebecca Segrave PhD, George Youssef PhD, Nadia Solowij PhD, Murat Yücel PhD

Article Type

Original Research

Published

This study investigated whether the legal status of cannabis in the USA is associated with problematic cannabis use and impulsivity in frequent cannabis users.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.